FDA Inspection 1079455 — Octapharma Dessau GmbH
The FDA completed an inspection of Octapharma Dessau GmbH on Nov 15, 2018 in Dessau-Roslau. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 15, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dessau-Roslau (Germany)